ALAMEDA, Calif., Feb. 27, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, announced today that President and Chief Executive Officer Kenneth Chahine, Ph.D., J.D., will participate in the “Future Directions and Novel Mechanisms of Action” panel on Tuesday, March 6, 2007, from 2:40 to 2:55 p.m. EST as part of the Oppenheimer “Positioning Investors for the Next Wave in Pain Management” Conference being held at the Flatotel Hotel in New York City.
